specifically addressed metabolic reprogramming in CRC, yet their analysis encompassed a wide range of pathways without a focused examination of mitochondrial metabolism or its role in therapy resistance [23]
Studies utilizing Alzheimers disease models suggest that semaglutide treatment inhibits the activation of microglia and astrocytes, thereby reducing the release of pro-inflammatory mediators (Zhai et al., 2025)
Postbiotics, including heat-inactivated bacteria, have demonstrated real biological activity in multiple studies
This is especially important for people with digestive issues who may not be able to absorb oral supplements well at all
GIP was long considered a problematic hormone in obesity research because it appeared to promote fat storage
Erlandson, Triin Umbleja, Heather J